Krai Chatamra

Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study

C. Warren Olanow, Karl Kieburtz, Per Odin et al. · The Lancet Neurology · 2013 · 683 citations

Advanced Parkinson, Continuous Intrajejunal Infusion, Neurology +3

Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results

Hubert H. Fernandez, David G. Standaert, Robert A. Hauser et al. · Movement Disorders · 2014 · 236 citations · Full text

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder

Stuart Montgomery, Krai Chatamra, L. Pauer et al. · The British Journal of Psychiatry · 2008 · 131 citations · Full text

Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson’s Disease Patients

Dag Nyholm, Per Odin, Anders Johansson et al. · The AAPS Journal · 2012 · 120 citations · Full text

Pharmacology, Clinical Pharmacology, Pharmacotherapy +4

Long-Term Safety and Maintenance of Efficacy of Levodopa-Carbidopa Intestinal Gel: An Open-Label Extension of the Double-Blind Pivotal Study in Advanced Parkinson's Disease Patients

John T. Slevin, Hubert H. Fernandez, Cindy Zadikoff et al. · Journal of Parkinson s Disease · 2015 · 101 citations · Full text